Board member
Thomas London is a board member of Oslo Cancer Cluster and Oslo Cancer Cluster Incubator, and CEO of Oslo Science Hub — a flagship initiative to expand Campus Radiumhospitalet into a dynamic ecosystem for cancer innovation. Oslo Science Hub is envisioned as a 40,000-square-meter collaborative space where academia, startups, scale-ups, and global pharmaceutical companies converge to accelerate cancer research and treatment. Completion is expected by 2030.
With a background in entrepreneurship, Thomas brings both strategic insight and practical experience to his roles. At the heart of his leadership is a commitment to shaping a fully integrated ecosystem where innovation thrives — not in isolation, but through the strength of connections between people, disciplines, and ideas.
His ambition is to help strengthen Campus Radiumhospitalets goal as being a leading international destination for oncology development — a living, breathing innovation ecosystem that fuels the next generation of cancer solutions.